181 related articles for article (PubMed ID: 2503862)
1. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.
Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G
Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862
[TBL] [Abstract][Full Text] [Related]
2. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
4. Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation.
Scopsi L; Andreola S; Pilotti S; Bufalino R; Baldini MT; Testori A; Rilke F
Am J Surg Pathol; 1994 Jul; 18(7):702-11. PubMed ID: 8017565
[TBL] [Abstract][Full Text] [Related]
5. Expression of the neuroendocrine phenotype in carcinomas of the breast.
Sapino A; Righi L; Cassoni P; Papotti M; Pietribiasi F; Bussolati G
Semin Diagn Pathol; 2000 May; 17(2):127-37. PubMed ID: 10839613
[TBL] [Abstract][Full Text] [Related]
6. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
8. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
[TBL] [Abstract][Full Text] [Related]
9. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study.
van Krimpen C; Elferink A; Broodman CA; Hop WC; Pronk A; Menke M
Breast; 2004 Aug; 13(4):329-33. PubMed ID: 15325669
[TBL] [Abstract][Full Text] [Related]
10. Biological characteristics of breast carcinomas with neuroendocrine cell differentiation.
Yao GY; Zhou JL; Zhao ZS; Ruan J
Chin Med J (Engl); 2004 Oct; 117(10):1536-40. PubMed ID: 15498379
[TBL] [Abstract][Full Text] [Related]
11. Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: an analysis of 310 reported cases.
Soga J; Osaka M; Yakuwa Y
Int Surg; 2001; 86(1):26-32. PubMed ID: 11890336
[TBL] [Abstract][Full Text] [Related]
12. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural features of neuroendocrine differentiated carcinomas of the breast.
Capella C; Usellini L; Papotti M; Macrì L; Finzi G; Eusebi V; Bussolati G
Ultrastruct Pathol; 1990; 14(4):321-34. PubMed ID: 2200185
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
Miettinen M
Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954
[TBL] [Abstract][Full Text] [Related]
16. [Glycogen-rich clear-cell breast carcinoma with neuroendocrine differentiation features].
Di Tommaso L; Pasquinelli G; Portincasa G; Santini D
Pathologica; 2001 Dec; 93(6):676-80. PubMed ID: 11785121
[TBL] [Abstract][Full Text] [Related]
17. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
18. [Amphicrine, mucoid and argyrophile tumors of the breast. Histochemical and ultrastructural study of 2 cases].
Berger G; Frappart L; Guillaud M; Mallet-Guy Y; Patricot LM; Feroldi J
Ann Pathol; 1982; 2(3):213-22. PubMed ID: 6289847
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine differentiation in ovarian mucinous tumors.
Jiang C; Tan Y; Li E; Zhang D
Chin Med J (Engl); 2000 Jan; 113(1):70-4. PubMed ID: 11775215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
